Stocks › PROF

Profound Medical Corp.

PROF·Nasdaq·Canada Canada·USD
$6.38
-0.21 (-3.19%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
PROF
Profound Medical Corp. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PROFS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of PROF by members of U.S. Congress · 4 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Tom MalinowskiTom MalinowskiHouse · D · NJ PROFProfound Medical Corp. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Jan 14, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ PROFProfound Medical Corp. · Stock Purchase
$1,001 - $15,000
Aug 26, 2021 Jan 27, 2020 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ PROFProfound Medical Corp. · Stock Purchase
$1,001 - $15,000
Mar 5, 2021 Dec 20, 2019 Filing ↗
Tom MalinowskiTom MalinowskiHouse · D · NJ PROFProfound Medical Corp. · Stock Purchase
$1,001 - $15,000
Mar 5, 2021 Jul 21, 2020 Filing ↗

Whale Activity

Position changes in PROF reported for 2026-09-30 by 63 institutional filers
Increased: 14New: 7Held: 18Decreased: 15Closed: 6No prior filing: 3
  • Increased14
  • New7
  • Held18
  • Decreased15
  • Closed6
  • No prior filing3
FilerSharesValueChange
FIL Ltd2.4M$13.9Mincreased
GAGNON SECURITIES LLC2.1M$11.9M—
ROYCE & ASSOCIATES LP1.2M$7.1Mincreased
Timelo Investment Management Inc.1.0M$5.9Mdecreased
Gagnon Advisors, LLC962.2K$5.6Mheld
LETKO, BROSSEAU & ASSOCIATES INC935.7K$5.2Mheld
Rosalind Advisors, Inc.828.1K$4.8Mheld
Z3 Capital Partners, LLC783.1K$4.5Mdecreased
MMCAP International Inc. SPC671.4K$3.9Mheld
ARDSLEY ADVISORY PARTNERS LP575.0K$3.3Mheld
Lagoda Investment Management, L.P.536.9K$3.1Mincreased
Ring Mountain Capital, LLC521.1K$3.0Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by PROF insiders, by quarter · Form 4
-25.0K-12.5K012.5K25.0K2025 Q1: 02025 Q12025 Q2: 22.0K2025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

15 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Menawat Arun SwarupCEO · Director Purchase +12.0K $4.73 $57K May 16, 2025 Form 4 ↗
Menawat Arun SwarupCEO · Director Purchase +10.0K $4.33 $43K May 15, 2025 Form 4 ↗
HOFER MICHAELDirector Sale −40.0K $0.16 $6K Dec 20, 2012 Form 4 ↗
HOFER MICHAELDirector Purchase −40.0K $0.16 $6K Dec 18, 2012 Form 4 ↗
SVEINSON FREDERICK JDirector Purchase +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
TEJADA FREDDirector Purchase Amended +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
BLANCHET JUSTINChief Financial Officer · Director Purchase Amended +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
ALIKAJ PERPARIMDirector Purchase Amended +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
KHORCHIDIAN RAFFI10% owner Sale −3.0M $0.00 $0 Jun 19, 2012 Form 4 ↗
KHORCHIDIAN RAFFI10% owner Other −52.0M $0.00 $0 Jun 19, 2012 Form 4 ↗
Schweitzer John H.Pres., CEO, Sec., Treas. · Director Purchase +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
HOFER MICHAELDirector Purchase +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
ALIKAJ PERPARIMDirector Gift +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
BLANCHET JUSTINChief Financial Officer · Director Gift +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗
TEJADA FREDDirector Gift +500.0K $0.00 $0 Jun 19, 2012 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding PROF · SEC Form N-PORT
FundSharesValue% of fundAs of
ROYCE MICRO-CAP TRUST, INC.742.8K$4.9M0.54%Jun 30, 2026
First Eagle Small Cap Opportunity Fund
First Eagle Funds
398.0K$2.9M0.10%Jul 31, 2026
Royce Micro-Cap Fund
ROYCE FUND
343.9K$2.3M0.53%Jun 30, 2026
Royce Capital Fund - Micro-Cap Portfolio
ROYCE CAPITAL FUND
112.9K$751K0.53%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund
Fidelity Concord Street Trust
26.7K$181K0.00%Aug 31, 2026
Invesco NASDAQ Future Gen 200 ETF
Invesco Exchange-Traded Fund Trust II
16.4K$112K0.50%Aug 31, 2026
The Canadian Small Company Series
DFA INVESTMENT TRUST CO
4,590$34K0.00%Jul 31, 2026
INTERNATIONAL CORE EQUITY 2 PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
3,806$28K0.00%Jul 31, 2026
Dimensional International Core Equity 2 ETF
Dimensional ETF Trust
1,891$14K0.00%Jul 31, 2026
Dimensional International Small Cap ETF
Dimensional ETF Trust
908$7K0.00%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list PROF's shares (CUSIP 74319B502), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Profound Medical Corp. as client

No lobbying filings found naming Profound Medical Corp. as the client.

Government Contracts

Federal awards to Profound Medical Corp. · USAspending

No federal contract awards found for Profound Medical Corp..

U.S. Patents

Recent USPTO applications naming Profound Medical Corp.

No USPTO patent applications found for Profound Medical Corp..

Annual Financials

From PROF's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023
Revenue$16.1M$10.7M$7.2M
Operating income-$41.3M-$33.1M-$28.7M
Net income-$42.6M-$27.8M-$28.3M
Diluted EPS$1.41$1.12$1.34
Operating cash flow-$38.2M-$23.5M-$22.6M
Cash and equivalents$59.7M$54.9M$26.2M
Total assets$77.5M$70.2M$44.0M
Total liabilities$11.0M$9.8M$12.7M
Shareholders' equity$66.4M$60.4M$31.2M

As Profound Medical Corp. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 5, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-10Reverse splitOct 16, 2019

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02Officer / director changeNov 12, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureNov 3, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 22, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 14, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 7, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureSep 4, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 3, 2026
    EDGAR ↗

About Profound Medical Corp.

From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersMISSISSAUGA, Ontario, Canada
IncorporatedA6